FBW BDL Intro

Successfully identify and execute strategic partnerships, licensing, and M&A Deals

The BD&L community is dedicated to dealmaking in the life sciences industry, bringing together cross-functional experts from pharma, biotech and VCs to share best practices in due diligence, capital raising and M&A, licensing, and strategic alliance transactions.  

Explore the dynamics of partnerships and investments in the life sciences industry, examine the changing landscape of deal structures and innovative licensing models, and gain insights that will unlock the potential of a deal and drive a company’s competitive position in the marketplace. 

Partnering for Success
Partnering for Success
Explore flexible partnership models, licensing deals, platform and non-asset deals, M&A opportunities, and build deal structures to maximize potential and profitable collaboration.
Deal Structuring
Deal Structuring
Examine the differences in valuation and alternative deal structures for creative financing.
Contract Negotiations
Contract Negotiations
Hear what it takes to draft and negotiate key contract terms to minimize future risk.
Due Diligence
Due Diligence
Gain insights on conducting a comprehensive and cost-effective due diligence assessment. 

Key topics covered in the BD&L track:​ 

  Deal Drivers and Investment Priorities for Big Pharma and VCs

  Operating Models for Search and Evaluation to Advance Innovation

  IP Due Diligence Issues that can Derail a Deal 

  Dealmaking Trends and Insights for New Modalities and Technologies

  Alternative Deal Constructs and Creative Financing 

  Negotiating and Evaluating Platform Deals 

BDL Topics